Literature DB >> 16737838

Long-term prognosis of patients with psychogenic movement disorders.

Madhavi Thomas1, Kevin Dat Vuong, Joseph Jankovic.   

Abstract

Psychogenic movement disorders (PMD) are hyper- or hypokinetic movement disorders associated with underlying psychological or psychiatric disorders. Structured telephone interview was administered to 228 patients with PMD seen in our clinic between 1990 and 2003. The mean age of the subjects was 42.3+/-14.3 years (range 14-70 years), mean duration of symptoms was 4.7+/-8.1 years (range 2-14 years), and mean duration of follow-up was 3.4+/-2.8 years (6 months-12 years). Improvement of symptoms was noted in 56.6% patients; while 22.1% were worse, and 21.3% remained the same at the time of follow-up. In this longitudinal study of patients with PMD we found that indices of strong physical health, positive social life perceptions, patient's perception of effective treatment by the physician, elimination of stressors, and treatment with a specific medication contributed to a favorable outcome.

Entities:  

Mesh:

Year:  2006        PMID: 16737838     DOI: 10.1016/j.parkreldis.2006.03.005

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  17 in total

1.  Inpatient treatment of functional motor symptoms: a long-term follow-up study.

Authors:  T A Saifee; P Kassavetis; I Pareés; M Kojovic; L Fisher; L Morton; J Foong; G Price; E M Joyce; M J Edwards
Journal:  J Neurol       Date:  2012-05-15       Impact factor: 4.849

Review 2.  Functional (psychogenic) movement disorders.

Authors:  Kathrin Czarnecki; Mark Hallett
Journal:  Curr Opin Neurol       Date:  2012-08       Impact factor: 5.710

3.  Psychogenic movement disorders.

Authors:  Elizabeth L Peckham; Mark Hallett
Journal:  Neurol Clin       Date:  2009-08       Impact factor: 3.806

4.  Psychogenic movement disorders and motor conversion: a roadmap for collaboration between neurology and psychiatry.

Authors:  Sarah M Kranick; Tristan Gorrindo; Mark Hallett
Journal:  Psychosomatics       Date:  2011 Mar-Apr       Impact factor: 2.386

5.  Characteristics of two distinct clinical phenotypes of functional (psychogenic) dystonia: follow-up study.

Authors:  Igor N Petrović; Aleksandra Tomić; Marija Mitković Vončina; Danilo Pešić; Vladimir S Kostić
Journal:  J Neurol       Date:  2017-11-15       Impact factor: 4.849

Review 6.  Treatment of functional (psychogenic) movement disorders.

Authors:  Luciana Ricciardi; Mark J Edwards
Journal:  Neurotherapeutics       Date:  2014-01       Impact factor: 7.620

Review 7.  Opinion: A role for placebo therapy in psychogenic movement disorders.

Authors:  Karen S Rommelfanger
Journal:  Nat Rev Neurol       Date:  2013-04-30       Impact factor: 42.937

Review 8.  The Phenomenology of Functional (Psychogenic) Dystonia.

Authors:  Christos Ganos; Mark J Edwards; Kailash P Bhatia
Journal:  Mov Disord Clin Pract       Date:  2014-04-10

9.  Psychogenic Movement Disorders in Adults and Children: A Clinical and Video Profile of 58 Indian Patients.

Authors:  Sanjay Pandey; Arun Koul
Journal:  Mov Disord Clin Pract       Date:  2017-07-18

Review 10.  Functional Movement Disorders and Placebo: A Brief Review of the Placebo Effect in Movement Disorders and Ethical Considerations for Placebo Therapy.

Authors:  Bonnie M Kaas; Casey Jo Humbyrd; Alexander Pantelyat
Journal:  Mov Disord Clin Pract       Date:  2018-10-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.